Crystal structure of 2-(2,3-dihydrobenzo[1,4]dioxin-6-yl)-5-(4-nitro benzylsulfanyl)-[1,3,4]oxadiazole, C17H13N3O5S
C17H13N3O5S, triclinic, P1̄ (no. 2), a = 7.199(1) Å, b = 8.002(2) Å, c = 14.547(3) Å, α = 96.722(2)°, β = 94.865(2)°, γ= 105.649(2)°, V = 795.5 Å3, Z = 2, Rgt(F) = 0.0390, wRref(F2) = 0.0955, T = 298 K.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2012-12-01
|
Series: | Zeitschrift für Kristallographie - New Crystal Structures |
Online Access: | https://doi.org/10.1524/ncrs.2012.0203 |